|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.250 SEK | +0.57% |
|
+1.94% | +14.13% |
| 07-24 | Active Biotech Doses First Patient in Amended Ho172 Clinical Study of Tasquinimod in Myelofibrosis | CI |
| 07-24 | Active Biotech Doses First Patient in Amended Tasquinimod Myelofibrosis Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.82% | +4.80% | +0.56% | +16.63% | +10.18% | +54.32% | +68.36% | +214.54% | +6,022.48% | 57.28B | |
| -0.27% | +5.74% | +5.48% | +24.56% | +37.53% | +40.26% | +80.17% | -16.19% | - | 54.99B | |
| -0.98% | -1.32% | +0.83% | -22.33% | -39.32% | +3.79% | +417.70% | +343.55% | +829.67% | 23.18B | |
| +2.95% | -0.24% | -2.46% | -9.92% | -3.42% | -18.49% | -12.44% | -67.63% | - | 22.59B | |
| -1.13% | +4.54% | +17.01% | +15.33% | +22.96% | +22.73% | -8.06% | -66.96% | - | 20.46B | |
| +1.57% | +3.30% | +11.03% | +11.78% | -5.87% | +27.41% | -29.07% | -30.74% | +59.93% | 17.56B | |
| -0.10% | +5.57% | +22.85% | +7.47% | +30.93% | +38.63% | +565.16% | - | - | 15.67B | |
| +5.29% | 0.00% | +14.77% | +113.80% | +182.04% | +185.09% | +332.66% | +1,569.75% | +674.23% | 14.46B | |
| +1.28% | +0.95% | +3.28% | +25.55% | +27.90% | +26.29% | +186.02% | +236.70% | +539.95% | 13.92B | |
| +2.45% | +3.45% | +5.10% | +6.55% | -4.84% | +88.39% | +177.19% | +547.61% | +7,288.80% | 12.55B | |
| +1.11% | +21.41% | +8.06% | +18.19% | +31.03% | +436.98% | +142.79% | +31.90% | +1,347.42% | 12.06B | |
| -0.90% | +11.60% | +18.37% | -25.08% | -12.74% | -33.87% | +153.80% | +104.56% | - | 11.69B | |
| -0.05% | +2.55% | -7.02% | +31.70% | +27.68% | +121.49% | +151.72% | +188.62% | +683.11% | 10.96B | |
| -1.72% | -0.56% | -6.25% | -39.31% | -23.24% | -51.09% | +595.60% | +77.34% | +87.76% | 10.9B | |
| -0.99% | +3.57% | +11.80% | +40.19% | +207.69% | +493.64% | +619.10% | -39.19% | -14.21% | 8.98B | |
| +0.22% | +0.05% | +127.16% | +117.27% | +80.26% | +176.94% | +354.56% | +375.15% | - | 8.83B | |
| +1.64% | +5.67% | +29.67% | +27.15% | +16.37% | +26.04% | +322.89% | +324.67% | - | 7.92B | |
| +1.74% | +0.25% | -3.60% | -6.83% | +20.59% | +55.12% | +20.35% | +153.49% | - | 7.89B | |
| -1.20% | -6.54% | -20.13% | -3.91% | +253.79% | +164.34% | +200.64% | -34.96% | - | 7.44B | |
| Average | +0.52% | +1.21% | +12.45% | +18.36% | +45.24% | +97.79% | +228.38% | +217.35% | +1,751.91% | 17.86B | |
| Weighted average by Cap. | +0.16% | +1.88% | +8.76% | +16.67% | +30.94% | +71.34% | +177.12% | +184.75% | +2,741.64% |
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
- Sector Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
